Correspondence 0001213900-25-010170 from 180 Life Sciences Corp. (ATNF, ATNFW) (CIK 0001690080) (ETHZ)
180 Life Sciences Corp. (ATNF, ATNFW) (CIK 0001690080)
Date: Feb. 4, 2025 · CIK: 0001690080 · Accession: 0001213900-25-010170
AI Filing Summary & Sentiment
File numbers found in text: 333-283265
Show Raw Text
CORRESP
1
filename1.htm
180 LIFE SCIENCES CORP.
3000 El Camino Real
Bldg. 4, Suite 200
Palo Alto, CA 94306
February 4, 2025
Division of Corporation Finance
VIA EDGAR
U.S. Securities and Exchange Commission
Washington D.C. 20549
Re: 180 Life Sciences Corp.
Form S-1 Registration Statement
File No. 333-283265
Acceleration Request
Request Date: February 7, 2025
Request Time: 4:00 p.m. Eastern Time (or
as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, 180 Life Sciences Corp. (the “Registrant”) hereby requests that the
United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-captioned
Registration Statement (the “Registration Statement”) to become effective at 4:00 p.m. Eastern Standard Time, Friday,
February 7, 2025, or as soon thereafter as practicable.
Please contact Mr. David M.
Loev of The Loev Law Firm, PC at (832) 930-6432, with any questions you may have concerning this request, and please notify him when this
request for acceleration has been granted.
Very truly yours,
/s/ Blair Jordan
Blair Jordan
Interim Chief Executive Officer